Eden Research plc, the AIM listed natural micro-encapsulation company, has signed a new Evaluation Agreement with Sipcam Italia Spa and Sipcam Iberia (collectively referred to as “Sipcam” and a Sumitomo-related company) to evaluate two new products targeting additional important crop diseases. In November 2014, Sipcam took an exclusive licence to Eden’s first product, 3AEY, for the treatment of botrytis. This product will be launched following the completion of the EU product registration allowing the sale and use of 3AEY on grapes, initially, across the Southern EU zone.
Following the successful work with 3AEY, Sipcam is expanding its evaluations of Eden’s technologies by conducting field trials on two new Eden products for the treatment of powdery mildew, which affects flowers and fruit, and apple scab during the course of 2015. These products are also based upon combinations of Eden’s EU approved terpenes and its patented micro-encapsulation technology, GO-E™. It is anticipated that Sipcam will expand its evaluations in 2016 and potentially begin the product registration process under a new licence from Eden should the trials prove to be conclusive during the course of 2015.
Financial terms of the Agreement are subject to confidentiality and have not been disclosed.
Sean Smith, Chief Executive Officer of Eden, said: “We are pleased with the increase in activities with our partner, Sipcam. This is clear evidence that we are realising the potential to expand the commercialisation of our products and grow the existing relationship with Sumitomo related companies around the world.
Powdery mildew and apple scab are both major diseases affecting high value crops, and we are eager to further demonstrate that we are able to leverage our technology platforms to provide natural solutions to important problems facing growers today. Furthermore, with the expansion of our set of products to tackle an ever-wider range of plant diseases, we are looking to provide the industry with new solutions in an environment in which regulation has typically limited the disease control options available today. We have long believed that our products are an essential component in effective integrated pest management, and we are pleased that our partners are continuing to find this to be the case.”
Giovanni Affaba, Managing Director of SIPCAM, said: "We are delighted with this new agreement representing further investment in building up a well-integrated portfolio of agrochemicals and natural products, able to highlight the well-known technical skills of our company to offer solutions to farmers able to satisfy their needs."